Table of Contents    
CORRESPONDENCE
Year : 2010  |  Volume : 1  |  Issue : 2  |  Page : 120
 

Valethamate bromide: Conflicting evidence and continuing use


1 Department of Pediatrics, Sri Lakshmi Narayana Institute of Medical Sciences (SLIMS), Osudu, Agaram Village, Puducherry, India
2 Department of Obstetrics and Gynecology, Indira Gandhi Medical College and Research Institute (IGMC&RI), Puducherry, India

Date of Web Publication10-Nov-2010

Correspondence Address:
Arun Babu Thirunavukkarasu
Department of Pediatrics, Sri Lakshmi Narayana Institute of Medical Sciences (SLIMS), Osudu, Agaram Village, Puducherry - 605 502
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0976-500X.72365

Rights and Permissions

 



How to cite this article:
Thirunavukkarasu AB, Sharmila V. Valethamate bromide: Conflicting evidence and continuing use. J Pharmacol Pharmacother 2010;1:120

How to cite this URL:
Thirunavukkarasu AB, Sharmila V. Valethamate bromide: Conflicting evidence and continuing use. J Pharmacol Pharmacother [serial online] 2010 [cited 2019 Nov 20];1:120. Available from: http://www.jpharmacol.com/text.asp?2010/1/2/120/72365


Dear Editor,

We read the editorial 'Valethamate bromide: Is there any proof of efficacy and safety for its use in labour?' by author Gitanjali B, with interest. [1] The editorial excellently describes the inadequate literature and unconvincing evidence regarding the use of valethamate bromide for cervical ripening and dilatation in labor. However, with due respect to the author, we would like to raise certain points. Firstly, we feel that the article is more biased and judgmental rather than being open to all currently available evidence. Contradictory to what is stated in the article, many clinical trials have shown that valethamate bromide is effective in facilitating cervical ripening, dilatation and thereby decreasing the duration of labor. [2],[3],[4],[5] But, the effect is not seen consistently and two trials have found no significant effect with the use of this drug. [6],[7]

We also wish to differ regarding the first of the three reasons suggested by the author for using this drug, which states 'that it is beneficial in crowded labor rooms to facilitate the reduction in time spent monitoring patient rather than a sound medical reason'. The most important reason for using this drug is to facilitate the labor process and reducing labor duration with an ultimate aim of reducing fetomaternal complications secondary to delayed or nonprogressive labor.

It is also important to remember that this drug has been used for almost three decades now and most of the clinicians have a good experience with this drug. Although few adverse effects like self-limiting maternal tachycardia can occur, which can be easily managed in low-risk patients, no major life-threatening adverse reactions have been reported till date. This should not prevent us from using this drug because the benefit is more than the posed risk. So we feel the debate whether or not to use this drug is still wide open and the current evidence does not warrant stoppage of using this drug. Large-scale multicentric randomized controlled clinical trials are needed before any major conclusions can be drawn in this regard.

 
   References Top

1.
Gitanjali B. Valethamate bromide: Is there any proof of efficacy and safety for its use in labor? J Pharmacol Pharmacother 2010;1:2-3.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Madhu C, Mahavarkar S, Bhave S. A randomised controlled study comparing Drotaverine hydrochloride and Valethamate bromide in the augmentation of labour. Arch Gynecol Obstet 2010;282:11-5.   Back to cited text no. 2
[PUBMED]  [Full text]  
3.
Sharma JB, Pundir P, Kumar A, Murthy NS. Drotaverine hydrochloride vs. valethamate bromide in acceleration of labor. Int J Gynaecol Obstet 2001;74:255-60.  Back to cited text no. 3
[PUBMED]  [Full text]  
4.
Batukan AC, Ozgün MT, Türkyilmaz C, Dolanbay M, Müderris II. The effect of valethamate bromide in acceleration of labor: A double-blind, placebo-controlled trial. J Turkish German Gynecol Assoc 2006;7:202-5.   Back to cited text no. 4
    
5.
Ajmera SK, Shah PK, Shinde GA. Comparative Study of Drotaverine v/s Valethamate in Cervical Phase of Labour. Bombay hospital journal. Available from: http://www.bhj.org/journal/2006_4802_april/html/org_res_305-309.html [last cited on 2010 Sep 7].  Back to cited text no. 5
    
6.
Kuruvila S, Jasper P, Peedicayil A, Mathai M. A randomized controlled trial of valethamate bromide in acceleration of labor. Int J Gynaecol Obstet 1992;38:93-6.   Back to cited text no. 6
[PUBMED]    
7.
Yilmaz B, Kart C, Kelekci S, Gokturk U, Sut N, Tarlan N, et al. Meperidine versus valethamate bromide in shortening the duration of active labor. Int J Gynaecol Obstet 2009;107:126-9.  Back to cited text no. 7
[PUBMED]  [Full text]  



This article has been cited by
1 Accessibility and potency of uterotonic drugs purchased by simulated clients in four districts in India
Cynthia Stanton,Deepak Nand,Alissa Koski,Ellie Mirzabagi,Steve Brooke,Breanne Grady,Luke C Mullany
BMC Pregnancy and Childbirth. 2014; 14(1): 386
[Pubmed] | [DOI]
2 Antispasmodics for labour
Anke C Rohwer,Oswell Khondowe,Taryn Young
Cochrane Database of Systematic Reviews. 2013;
[Pubmed] | [DOI]
3 Authoręs reply
Gitanjali B
J Pharmacol Pharmacother. 2010; 1(2): 120-121
[Pubmed]
4 Valethamate bromide: Is there any proof of efficacy and safety for its use in labor?
Gitanjali B.
J Pharmacol Pharmacother 2010;1:2-3. 2010; 1(1): 2-3
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
 
 
  Search
 
  
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (338 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1845    
    Printed163    
    Emailed1    
    PDF Downloaded309    
    Comments [Add]    
    Cited by others 4    

Recommend this journal